🔬
Head & Neck Cancer
India bears the highest global burden of head and neck cancers. Our program combines de-intensification strategies with novel immunotherapy approaches.
Learn MoreOur Researchers
See all
Dr. Jegan Thomas
Department of Molecular Oncology
Dr. Thangarajan Rajkumar
Department of Cancer Biology & Molecular Diagnostics
Dr. Shirley Sunder Singh
Department of Cancer Biology & Molecular Diagnostics
Dr. Rama Jayaraj
Department of Cancer Biology & Molecular Diagnostics
Dr. Arvind Krishnamurthy
Clinical Trials & Statistical Unit
Dr. Priya Nair
Department of Preventive Oncology
Research Themes
HPV-Negative Disease Biology
Genomic and epigenomic characterization of tobacco-driven head and neck cancers prevalent in the Indian population.
De-Intensification Strategies
Reducing treatment toxicity in favourable-prognosis patients through response-adapted radiation dose reduction.
Immunotherapy in Recurrent Disease
Evaluating novel checkpoint inhibitor combinations and tumour-infiltrating lymphocyte therapy for platinum-refractory cancers.
Swallowing & Speech Rehabilitation
Prospective studies on functional outcomes and quality of life after organ-preserving treatments.
Clinical Trials
NCT06234510
RecruitingNivolumab + Ipilimumab in Recurrent HPV-Negative HNSCC
PI: Dr. Arvind Krishnamurthy
NCT06234511
ActiveResponse-Adapted Radiation Dose Reduction in HPV+ Oropharyngeal Cancer
PI: Dr. Selvaluxmy Ganapathy
Support Head & Neck Cancer Research
Your contribution funds research into less toxic treatments that preserve speech, swallowing, and quality of life for patients with head and neck cancers.
Donate Now